This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Ludovic Collin: Innovator in Pharmaceutical Chemistry
Introduction
Ludovic Collin is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds.
Latest Patents
Ludovic holds a patent for "Piperazine derivatives as MAGL inhibitors." This invention provides new heterocyclic compounds characterized by a general Formula (I), or a pharmaceutically acceptable salt thereof. His work in this area has the potential to impact therapeutic applications significantly.
Career Highlights
Ludovic is currently employed at Hoffmann-La Roche Inc., a leading global healthcare company. His role involves research and development, focusing on innovative solutions in drug discovery and development.
Collaborations
He has collaborated with esteemed colleagues, including Joerg Benz and Uwe Grether, to advance research initiatives and enhance the effectiveness of their projects.
Conclusion
Ludovic Collin's contributions to pharmaceutical chemistry through his innovative patents and collaborative efforts highlight his importance in the field. His work continues to pave the way for advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile